JS Link, Inc. (KOSDAQ:127120)
33,000
+1,300 (4.10%)
At close: Sep 9, 2026
JS Link Revenue
JS Link had revenue of 6.31B KRW in the quarter ending June 30, 2026, with 64.43% growth. This brings the company's revenue in the last twelve months to 22.78B, up 51.26% year-over-year. In the year 2025, JS Link had annual revenue of 19.32B with 21.43% growth.
Revenue (ttm)
22.78B
Revenue Growth
+51.26%
P/S Ratio
50.34
Revenue / Employee
271.19M
Employees
84
Market Cap
1.15T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.32B | 3.41B | 21.43% |
| Dec 31, 2024 | 15.91B | -6.04B | -27.52% |
| Dec 31, 2023 | 21.95B | 4.97B | 29.26% |
| Dec 31, 2022 | 16.98B | -6.01B | -26.14% |
| Dec 31, 2021 | 22.99B | 7.71B | 50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 124.81B |
| Aimed Bio | 66.79B |
| ROKIT Healthcare | 32.81B |
| S.Biomedics | 16.49B |
| Qurient | 7.07B |
| IntoCell | 3.19B |
| Inventage Lab | 2.47B |
| AprilBio | 725.35M |